Skip to main content
Article
Abstract B01: Surgical outcomes following neoadjuvant hypofractionated radiation in combination with nivolumab: High rate of pathologic complete response in patients with p16+ head and neck squamous cell carcinoma
Clinical Cancer Research (2020)
  • R. Bryan Bell, Providence Cancer Institute, Portland, OR.
  • Rom Leidner, Providence Cancer Institute, Portland, OR.
  • Marcus Couey, Providence Cancer Institute, Portland, OR.
  • Ashish Patel, Providence Cancer Institute, Portland, OR.
  • Amber Watters, Providence Cancer Institute, Portland, OR.
  • Hong Ziao, Providence Cancer Institute, Portland, OR.
  • Carlo Bifulco, Providence Cancer Institute, Portland, OR.
  • Brian Piening, Providence Cancer Institute, Portland, OR.
  • George Morris, Providence Cancer Institute, Portland, OR.
  • Lessli Rushforth, Providence Cancer Institute, Portland, OR.
  • Dawn Brucker, Providence Cancer Institute, Portland, OR.
  • Shoren Nemeth, Providence Cancer Institute, Portland, OR.
  • Kristina Young, Providence Cancer Institute, Portland, OR.
  • Michael Gough, Providence Cancer Institute, Portland, OR.
  • Marka Crittenden, Providence Cancer Institute, Portland, OR.
Publication Date
June 15, 2020
DOI
10.1158/1557-3265.AACRAHNS19-B01
Citation Information
R. Bryan Bell, Rom Leidner, Marcus Couey, Ashish Patel, et al.. "Abstract B01: Surgical outcomes following neoadjuvant hypofractionated radiation in combination with nivolumab: High rate of pathologic complete response in patients with p16+ head and neck squamous cell carcinoma" Clinical Cancer Research Vol. 26 (2020)
Available at: http://works.bepress.com/carlo-bifulco/55/